JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
NKSH
National Bankshares, Inc.
NKSH has the edge over JPM overall, supported by stronger valuation and stronger fundamentals.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
NKSH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
NKSH's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like NKSH.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over NKSH in the historical PE scenario, which offers more potential upside but is not a forecast.
NKSH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $32.39 | -18% |
| Forward | 10x | $39.59 | — |
| Current | 12x | $39.59 | — |
| Fair | 13x | $42.43 | +7.2% |
| Expensive | 17x | $56.42 | +42% |
Historical ranges are pointers, not guarantees.
NKSH's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
NKSH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
NKSH has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
NKSH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.85 | +15% |
| Q3 2026 | $3.36 | +63% |
| Q2 2026 | $3.19 | +78% |
| Q1 2026 | $2.76 | +100% |
| Q4 2025 | $2.49 | +101% |
| Q3 2025 | $2.06 | +42% |
| Q2 2025 | $1.79 | +15% |
| Q1 2025 | $1.38 | -39% |
| Q4 2024 | $1.24 | -53% |
NKSH earned $3.36 per share over the past year, up 63% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
NKSH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.4M | +16% |
| Q2 2026 | $15.7M | +18% |
| Q1 2026 | $15.3M | +19% |
| Q4 2025 | $15.3M | +25% |
| Q3 2025 | $14.2M | +21% |
| Q2 2025 | $13.3M | +21% |
| Q1 2025 | $12.8M | +23% |
| Q4 2024 | $12.2M | +14% |
NKSH has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 41% | +3.4 points |
| Q2 2026 | 39% | +19 points |
| Q1 2026 | 40% | +9.1 points |
| Q4 2025 | 47% | +17 points |
| Q3 2025 | 38% | +10 points |
| Q2 2025 | 20% | +24 points |
| Q1 2025 | 30% | +4.7 points |
| Q4 2024 | 30% | -17 points |
NKSH has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
NKSH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $7.1M | +33% |
| Q2 2026 | $3.3M | +118% |
| Q1 2026 | $3.1M | +92% |
| Q4 2025 | $6.7M | +50% |
| Q2 2025 | $1.5M | +$4.5M |
| Q1 2025 | $1.6M | -58% |
| Q2 2024 | -$2.9M | -173% |
| Q1 2024 | $3.8M | -11% |
NKSH has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over NKSH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
NKSH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.3K shares |
| 1 year | +0.1% | +5.1K shares |
| 3 years | +8.1% | +479K shares |
| 5 years | +3.7% | +226K shares |
| Available history | -3.2% | -212K shares |
NKSH has 6M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $2.6M |
| Q3 2022 | $796,000 |
| Q2 2022 | $1.4M |
| Q1 2022 | $1.5M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
NKSH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.7x | Net Cash |
| Q4 2025 | -2.9x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -6.3x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2024 | -10.5x | Net Cash |
NKSH has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
NKSH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 18.9 | Oversold |
NKSH's weekly RSI is 50 (neutral) and its Stochastic is 19 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
NKSH PE vs Financial Services Sector
| Metric | NKSH | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 9.5% below |
| PE % | 42 | 63 | 21 pts below |
NKSH has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over NKSH on trend strength, trading above more of its moving averages.
NKSH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $41.3 | 4.2% below |
| 20 week MA | $40.6 | 2.4% below |
| 50 week MA | $37.7 | 5% above |
| 100 week MA | $32.9 | 20% above |
| 200 week MA | $31.8 | 25% above |
NKSH has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 25% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
NKSH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.1 | $31.7 | -31% |
| 2021 | $31.7 | $35.6 | +12% |
| 2022 | $35.6 | $39.8 | +12% |
| 2023 | $39.8 | $32.4 | -19% |
| 2024 | $32.4 | $28.4 | -12% |
| 2025 | $28.4 | $33.9 | +19% |
| 2026 YTD | $33.9 | $39.6 | +17% |
NKSH has the edge over JPM on returns for 2026, with the stronger performance.